Dana Farber Cancer Institute SC-7 — Boston, Massachusetts

Dana Farber Cancer Institute SC-7 is a clinical research site located in Boston, Massachusetts, United States 02215.

Crixeo Health Trust Score: 64/100 (FAIR). This profile has not yet been claimed by the site owner.

Dana Farber Cancer Institute SC-7 has participated in 3 clinical trials.

Therapeutic areas: Malignant Rhabdoid Tumors (MRT), Neuroblastoma, Pancreatic Cancer.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 64/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Dana Farber Cancer Institute SC-7?

Dana Farber Cancer Institute SC-7 has a Crixeo Trust Score of 64/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Dana Farber Cancer Institute SC-7 conducted?

Dana Farber Cancer Institute SC-7 has 3 clinical trials on record. Their work covers Malignant Rhabdoid Tumors (MRT), Neuroblastoma, Pancreatic Cancer.

Is Dana Farber Cancer Institute SC-7 accredited by Crixeo Health?

Dana Farber Cancer Institute SC-7 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Dana Farber Cancer Institute SC-7?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.